Glycorex Transplantation AB (publ)

At a glance

Most recent filing on May 24, 2023 — an open-market purchase by Johan Lavén on May 24, 2023.

We hold 19 visible filings, going back to December 20, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 19 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 19. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Johan Lavén Chief executive officer
42,900 SEKOpen-market buy
TradedMay 24, 2023FiledMay 24, 2023
Johan Lavén Chief executive officer
20,000 SEKOpen-market buy
TradedMar 24, 2023FiledMar 24, 2023
Johan Lavén Chief executive officer
40,300 SEKOpen-market buy
TradedJan 4, 2023FiledJan 4, 2023
Johan Lavén Chief executive officer
73,270 SEKOpen-market buy
TradedDec 9, 2022FiledDec 13, 2022
Geert Nygaard Chief executive officer
616,000 SEKOpen-market buy
TradedFeb 24, 2022FiledFeb 24, 2022